Sonoma Pharmaceuticals (SNOA) Income from Continuing Operations (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted Income from Continuing Operations of -$330000.0 for Q2 2026, up 43.2% on a QoQ basis from -$581000.0 in Q1 2026, and up 73.41% year-over-year from -$190302.0 in Q2 2025.
Powered by 
Analysis
Sonoma Pharmaceuticals (SNOA) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals has reported Income from Continuing Operations for 17 years, with the latest figure at -$330000.0 in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 73.41% year-over-year to -$330000.0 in Q2 2026; TTM through Jun 2026 was -$2.3 million, a 36.32% increase from a year earlier, with the FY2026 full-year figure at -$3.2 million, up 8.16% from the prior year.
- Income from Continuing Operations was -$330000.0 for Q2 2026 at Sonoma Pharmaceuticals, up from -$581000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was -$330000.0 in Q2 2026, with the low at -$3.8 million in Q1 2022.
- Average Income from Continuing Operations over 5 years is -$1.2 million, with a median of -$972500.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations plunged 917.0% in 2022, then soared 73.41% in 2026.
- Over 5 years, Income from Continuing Operations stood at -$1.9 million in 2022, then surged by 55.34% to -$866000.0 in 2023, then slipped by 7.16% to -$928000.0 in 2024, then rose by 11.75% to -$819000.0 in 2025, then jumped by 59.71% to -$330000.0 in 2026.
- The last three Income from Continuing Operations figures came in at -$330000.0 (Q2 2026), -$581000.0 (Q1 2026), and -$819000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.37 Bn | 48.51 Bn | 2.32 Bn | 452.00 Mn |
| 2 | Medline | 29.46 Bn | 26.78 Bn | 2.22 Bn | 139.00 Mn |
| 3 | West Pharmaceutical Services | 23.97 Bn | 23.53 Bn | 329.20 Mn | 147.90 Mn |
| 4 | Baxter International | 12.79 Bn | 10.64 Bn | 1.03 Bn | 135.00 Mn |
| 5 | Stevanato Group S.p.A | 5.49 Bn | 5.38 Bn | 100.91 Mn | 26.68 Mn |
| 6 | Acme United | 233.10 Mn | 228.06 Mn | 26.69 Mn | 5.05 Mn |
| 7 | Rockwell Medical | 31.61 Mn | 6.81 Mn | 3.24 Mn | -1.30 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 2.24 Mn |
| 9 | United Health Products | 8.37 Mn | 8.34 Mn | - | -217,306.00 |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | -330,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -330,000.00 |
| Mar 31, 2026 | -581,000.00 |
| Dec 31, 2025 | -819,000.00 |
| Sep 30, 2025 | -534,000.00 |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -776,000.00 |
| Dec 31, 2024 | -928,000.00 |
| Sep 30, 2024 | -610,000.00 |
| Jun 30, 2024 | -1.14 Mn |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | -866,000.00 |
| Sep 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.42 Mn |
| Mar 31, 2023 | -1.31 Mn |
| Dec 31, 2022 | -1.94 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -887,000.00 |
| Mar 31, 2022 | -3.75 Mn |
| Dec 31, 2021 | -944,000.00 |
| Sep 30, 2021 | -100,000.00 |